Croissy-Beaubourg and Montpellier, March 28, 2017, 8am CEST – Theradiag (ISIN: FR0004197747, ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, is today announcing further progress in bringing its LISA TRACKER® monitoring tests…
Very strong revenue growth of 19% Ramp-up in Theranostics to €4 million or 45% of total revenuesSignificant reduction in the operating lossStrengthening of the cash position: €3.7 million Croissy-Beaubourg and Montpellier, March 1, 2017, 5:45pm (CET) – THERADIAG…
Board of Directors strengthened to support the Company’s strategic development Croissy-Beaubourg and Montpellier, March 1, 2017, 5:45pm (CET) – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, has today…